Characterization of inhalation aerosols: a critical evaluation of cascade impactor analysis and laser diffraction technique.

Cascade impactor analysis is the standard technique for in vitro characterization of aerosol clouds generated by medical aerosol generators. One important reason for using this inertial separation principle is that drug fractions are classified into aerodynamic size ranges that are relevant to the deposition in the respiratory tract. Measurement of these fractions with chemical detection methods enables establishment of the particle size distribution of the drug in the presence of excipients. However, the technique is laborious and time consuming and most of the devices used for inhaler evaluation lack sufficient possibilities for automation. In addition to that, impactors often have to be operated under conditions for which they were not designed and calibrated. Particularly, flow rates through impactors are increased to values at which the flow through the nozzles is highly turbulent. This has an uncontrolled influence on the collection efficiencies and cut-off curves of these nozzles. Moreover, the cut-off value varies with the flow rate through an impactor nozzle. On the other hand, the high air flow resistances of most impactors are rather restricting to the attainable (fixed) inspiratory flow curves through these devices. Especially for breath actuated dry powder inhalers, higher flow rates and flow increase rates may be desirable than can be achieved in combination with a particular type of impactor. In this paper, the applicability of laser diffraction technology is evaluated as a very fast and highly reliable alternative for cascade impactor analysis. With this technique, aerodynamic diameters cannot be measured, but for comparative evaluation and development, comprising most in vitro applications, this is not necessary. Laser diffraction has excellent possibilities for automated recording of data and testing conditions, and the size classes are independent of the flow rate. Practical limitations can be overcome by using a special inhaler adapter which enables control of the inspiratory flow curve through the inhaler, analysis of the emitted fine particle mass fraction and pre-separation of large particles during testing of dry powder inhalers containing adhesive mixtures.

[1]  K. Taylor,et al.  Nebulisers for the generation of liposomal aerosols , 1998 .

[2]  M. L. Laucks,et al.  Aerosol Technology Properties, Behavior, and Measurement of Airborne Particles , 2000 .

[3]  G. Hanlon,et al.  An investigation into the deposition of inhalation aerosol particles as a function of air flow rate in a modified ‘Kirk Lung’ † , 1976, The Journal of pharmacy and pharmacology.

[4]  Peter R. Byron,et al.  Cascade impaction methods for dry powder inhalers using the high flowrate Marple-Miller impactor , 1996 .

[5]  G. Bolhuis,et al.  Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers: Part 3: the effect of flow increase rate (FIR) on the in vitro drug release from the Pulmicort 200 Turbuhaler , 1997 .

[6]  I. Kellaway,et al.  PARTICLE SIZE ANALYSIS OF NEBULISED AEROSOLS USING FRAUNHOFER LASER DIFFRACTION AND INERTIAL COMPACTION METHODS , 1986 .

[7]  Bo Olsson,et al.  Calibration at Different Flow Rates of a Multistage Liquid Impinger , 1997 .

[8]  Ananth Annapragada,et al.  An analysis of the fraunhofer diffraction method for particle size distribution analysis and its application to aerosolized sprays , 1996 .

[9]  A Brindley,et al.  The characterisation of inhalation devices by an inhalation simulator: The Electronic Lung. , 1994, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[10]  N Lotan,et al.  Large porous particles for pulmonary drug delivery. , 1997, Science.

[11]  Anthony J. Hickey,et al.  An Investigation of Size Deposition Upon Individual Stages of a Cascade Impactor , 1990 .

[12]  S. K. Tee,et al.  Drug Delivery to the Lungs XI , 2001 .

[13]  T. Martonen,et al.  Deposition Patterns of Aerosolized Drugs Within Human Lungs: Effects of Ventilatory Parameters , 1993, Pharmaceutical Research.

[14]  P. Hurley,et al.  Assessment of antibiotic aerosol generation using commercial jet nebulizers. , 1994, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[15]  A. Clark The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulizers , 1995 .

[16]  F. Morén,et al.  Dosage Forms and Formulations for Drug Administration to the Respiratory Tract , 1987 .

[17]  R. Niven,et al.  Development and use of an in vitro system to evaluate inhaler devices , 1994 .

[18]  K. Taylor,et al.  Nebulization of Fluids of Different Physicochemical Properties with Air-Jet and Ultrasonic Nebulizers , 1995, Pharmaceutical Research.

[19]  W. E. Ranz,et al.  Jet impactors for determining the particle-size distributions of aerosols. , 1952, A.M.A. archives of industrial hygiene and occupational medicine.

[20]  W. E. Ranz,et al.  Impaction of Dust and Smoke Particles on Surface and Body Collectors. , 1952 .

[21]  O.N.M. Mc Callion,et al.  The influence of surface tension on aerosols produced by medical nebulisers , 1996 .

[22]  Ranz We,et al.  Jet impactors for determining the particle-size distributions of aerosols. , 1952 .

[23]  P. Byron Some Future Perspectives for Unit Dose Inhalation Aerosols , 1986 .

[24]  W. John A SIMPLE DERIVATION OF THE CUTPOINT OF AN IMPACTOR , 1999 .